• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Model Number 6L45-42
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/09/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Was this device serviced by a third party? no.Patient information: no further information was provided.This issue was previously reported under mdr number 3016438761-2021-00151 under the same suspect medical device but an incorrect manufacturer name, city and state.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer obtained a falsely depressed architect total bilirubin result.On (b)(6) 2021 sample id (b)(6) generated 16.4 and repeat 117 umol/l.No impact to patient management was reported.
 
Additional Manufacturer Narrative
A review of tickets determined that there is normal complaint activity for lot number 58020uq08.Trending review for the architect total bilirubin assay determined there were no trends for false depressed patient results.Return testing was not completed as returns were not available.The complaint data states the customer is happy with instrument performance and believes the sample was short as it was pediatric sample.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the architect total bilirubin reagent lot 58020uq08 was identified.This follow up is being submitted to include d8 and h6 information previously submitted using the h10 section in their respective fields.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Common Device Name
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key11756820
Report Number3002809144-2021-00282
Device Sequence Number3192644
Product Code CIG
UDI-Device Identifier00380740174972
UDI-Public00380740174972
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K121985
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2022
Device Model Number6L45-42
Device Catalogue Number06L45-42
Device Lot Number58020UQ08
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 04/21/2021
Supplement Date Received by Manufacturer05/07/2021
Initial Report FDA Received Date04/30/2021
Supplement Report FDA Received Date05/26/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC C16K PRC MOD, 03L77-01, (B)(4); ARC C16K PRC MOD, 03L77-01, (B)(4)
-
-